← Back to patent-cliff list

CAS 402-45-9

4-(trifluoromethyl)phenol4-(Trifluoromethyl)phenol

Codes: SELALD-001, (V)236036-1-a, (A)131699-1-a, (V)263642-3-a

Application context (from source-drug indications)

Biliary cirrhosisSeladelpar lysine dihydrateSclerosing cholangitisSeladelpar lysine dihydrateLiver cirrhosisSeladelpar lysine dihydrateHepatic function declineSeladelpar lysine dihydrateFibrosisSeladelpar lysine dihydrateNon-alcoholic steatohepatitisSeladelpar lysine dihydrate分离性焦虑S-fluoxetineAnxietyS-fluoxetineAnxiety disorderS-fluoxetine分离性焦虑R-fluoxetineAnxietyR-fluoxetineAnxiety disorderR-fluoxetine

Source drugs (routes using this intermediate)

DrugTierExpiry
Seladelpar lysine dihydrateTier C — Watch / trade-
S-fluoxetineTier C — Watch / trade-
R-fluoxetineTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

R-fluoxetineOptimised routesteps: 6total yield: /

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.